Abstract:Abstract High-parameter flow cytometry provides a powerful tool for in-depth analysis of CAR T cell therapy, from characterizing CAR T cell populations to understanding their interactions within the tumor microenvironment. This information is crucial for advancing CAR T cell therapies and improving their effectiveness in treating cancer. To address the need for deep immunoprofiling at all stages of CAR T cell therapy, we created a robust and comprehensive mass cytometry panel of antibodies against 44 cell surface and intracellular markers. This assay allows for comprehensive characterization of CAR T cell features including surface marker expression, activation state, cytokine production, and differentiation status. These data will provide researchers with a better understanding of the phenotype of the CAR T cells used in therapy and can guide optimization efforts to enhance expansion, persistence, and self-renewal. For example, newer-generation CAR T cells (T cells redirected for antigen-unrestricted cytokine-initiated killing, or TRUCKs) that are engineered to produce cytokines such as IL-2 to enhance their own survival can be evaluated in vitro to select CAR constructs with the most potent anti-tumor activity. The lyophilized and validated 30-marker Maxpar® DirectTM Immune Profiling AssayTM enables comprehensive characterization of immune cell populations in both whole blood and PBMC. The 7-marker Maxpar Direct T Cell Expansion Panel 3 (OX40, TIGIT, CD69, PD-1, Tim-3, ICOS, and 4-1BB) and the Maxpar Direct Basic Activation Expansion Panel (CD107a, IL-2, TNFα, IFNγ, perforin, and granzyme B) are add-on modules that can further characterize CAR T cell exhaustion, degranulation, cytokine production, and cytotoxicity against target cells. We also compared CAR T detection options for sensitivity and specificity using a CD19 CAR-transduced cell line spiked into healthy donor PBMC. Indirect staining with Miltenyi Biotec biotinylated CD19 CAR Detection Reagent followed by anti-biotin- or streptavidin-conjugated metal tags was compared against a directly conjugated or biotinylated anti-G4S linker antibody. We included sample multiplexing using 6 metal-tagged CD45 antibodies to address the need to minimize batch effects, crucial to multi-site and longitudinal studies. Samples were acquired on a CyTOF® XTTM instrument, and preliminary data analysis was performed using Maxpar PathsetterTM for automated enumeration of immune cells. By combining the lyophilized single-tube Maxpar Immune Profiling Assay and Expansion Panels with specific detection of CAR T cells, this assay enables researchers to analyze multiple key parameters simultaneously at the single-cell level at all stages of CAR T therapy development. For Research Use Only. Not for use in diagnostic procedures. Citation Format: Deeqa Mahamed, Geneve Awong, Thiru Selvanatham. A high-parameter mass cytometry panel for the functional characterization of CAR T cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6333.

High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity against Solid Tumor Cell Lines

High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity against Solid Tumor Cell Lines

High‐Throughput Image Cytometry Detection Method for CAR‐T Transduction, Cell Proliferation, and Cytotoxicity Assays

Abstract 5326: Comparison of CAR-T cell-mediated cytotoxicity assays with suspension tumor cells using high-throughput plate-based image cytometry method

Comparison of CAR-T cell-mediated cytotoxicity assays with suspension tumor cells using high-throughput plate-based image cytometry method

Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy

Abstract 4575: High-throughput method to analyze the cytotoxicity of CAR T cells in a 3D tumor spheroid model using image cytometry

Assessment of Chimeric Antigen Receptor T Cytotoxicity by Droplet Microfluidics in Vitro

Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells

A Flow Cytometry-Based Method for Assessing CAR Cell Binding Kinetics Using Stable CAR Jurkat Cells

Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity

Abstract 6424: A patient centric full spectrum flow cytometry assay for comprehensive phenotyping of CAR T cells in clinical trials

A Real-Time Potency Assay For Chimeric Antigen Receptor T Cells Targeting Solid And Hematological Cancer Cells

Abstract 6333: A high-parameter mass cytometry panel for the functional characterization of CAR T cells

Abstract 5242: In vitro cytotoxicity assays to support CAR T cell evaluation against solid tumors

Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices

Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood

Comparison of CAR‐T cell‐mediated cytotoxicity assays with suspension tumor cells using plate‐based image cytometry method

Optimizing ex vivo CAR-T cell-mediated cytotoxicity assay through multimodality imaging

Monitoring CAR T‐cells using flow cytometry

A Versatile Flow-Based Assay for Immunocyte-Mediated Cytotoxicity.